Finance

Lists
0NN:FRA
Avicanna Inc
€0.077
+0.65%
(+0.00050) 1D
Aug 28, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 0NN...
Open
€0.08
High
€0.08
Low
€0.08
Mkt. cap
17.90M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.19
52-wk low
€0.06
No. of employees
112
Open
€0.08
High
€0.08
Low
€0.08
Mkt. cap
17.90M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.19
52-wk low
€0.06
No. of employees
112
About Avicanna Inc
CEOAras Azadian
Employees112
Founded2016
HeadquartersToronto, Ontario, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.40M
6.60M
6.68M
5.64M
Cost of goods sold
3.25M
2.96M
2.84M
2.45M
Cost of revenue
3.25M
2.96M
2.84M
2.45M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.88M
3.75M
3.91M
3.62M
Operating expense
4.52M
4.44M
4.15M
4.26M
Total operating expenses
7.77M
7.40M
6.99M
6.70M
Operating income
-1.37M
-803.78K
-309.02K
-1.06M
Other non operating income
1.04K
78.48K
41.38K
-215.30K
EBT including unusual items
-1.38M
-749.85K
-288.90K
-1.31M
EBT excluding unusual items
-1.38M
-749.85K
-288.90K
-1.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.38M
-749.85K
-288.90K
-1.31M
Net profit margin
-21.62%
-11.36%
-4.32%
-23.28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-5.35K
-14.79K
-15.62K
-27.23K
Net interest expenses
-5.35K
-14.79K
-15.62K
-27.23K
Depreciation and amortization charges
193.89K
164.60K
165.30K
171.88K
EBITDA
-1.24M
-664.83K
-143.72K
-942.79K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps